• Login
    View Item 
    •   UMB Digital Archive
    • UMB Open Access Articles
    • UMB Open Access Articles
    • View Item
    •   UMB Digital Archive
    • UMB Open Access Articles
    • UMB Open Access Articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UMB Digital ArchiveCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    Trial design for assessing analytical and clinical performance of high-sensitivity cardiac troponin I assays in the United States: The HIGH-US study

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Publisher version
    View Source
    Access full-text PDFOpen Access
    View Source
    Check access options
    Check access options
    Author
    Christenson, R.H.
    Peacock, W.F.
    Apple, F.S.
    Date
    2019
    Journal
    Contemporary Clinical Trials Communications
    Publisher
    Elsevier Inc
    Type
    Article
    
    Metadata
    Show full item record
    See at
    https://dx.doi.org/10.1016/j.conctc.2019.100337
    Abstract
    Background: High-sensitivity cardiac troponin I (hs-cTnI) assays have been developed that quantify lower cTnI concentrations with better precision versus earlier generation assays. hs-cTnI assays allow improved clinical utility for diagnosis and risk stratification in patients presenting to the emergency department with suspected acute myocardial infarction. We describe the High-Sensitivity Cardiac Troponin I Assays in the United States (HIGH-US) study design used to conduct studies for characterizing the analytical and clinical performance of hs-cTnI assays, as required by the US Food and Drug Administration for a 510(k) clearance application. This study was non-interventional and therefore it was not registered at clinicaltrials.gov. Methods: We conducted analytic studies utilizing Clinical and Laboratory Standards Institute guidance that included limit of blank, limit of detection, limit of quantitation, linearity, within-run and between run imprecision and reproducibility as well as potential interferences and high dose hook effect. A sample set collected from healthy females and males was used to determine the overall and sex-specific cTnI 99th percentile upper reference limits (URL). The total coefficient of variation at the female 99th percentile URL and a universally available American Association for Clinical Chemistry sample set (AACC Universal Sample Bank) from healthy females and males was used to examine high-sensitivity (hs) performance of the cTnI assays. Clinical diagnosis of enrolled subjects was adjudicated by expert cardiologists and emergency medicine physicians. Assessment of temporal diagnostic accuracy including sensitivity, specificity, positive predictive value, and negative predictive value were determined at presentation and collection times thereafter. The prognostic performance at one-year after presentation to the emergency department was also performed. This design is appropriate to describe analytical characterization and clinical performance, and allows for acute myocardial infarction diagnosis and risk assessment. © 2019
    Sponsors
    Dr. R.H. Christenson has received fees from Siemens Healthineers for consultancy work on design and conduct of high-sensitivity cardiac troponin I clinical trials, and is a consultant for Siemens Healthineers, Roche Diagnostics, Quidel Diagnostics, and Beckman Coulter. Dr. F. Peacock has received research Grants from Abbott , Braincheck , Immunarray , Janssen , Ortho Clinical Diagnostics , Relypsa , Roche . He has served as a consultant to Abbott, Astra-Zeneca, Bayer, Beckman, Boehrhinger-Ingelheim, Ischemia Care, Dx, Immunarray, Instrument Labs, Janssen, Nabriva, Ortho Clinical Diagnostics, Relypsa, Roche, Quidel, and Siemens Healthineers. He has provided expert testimony for Johnson and Johnson, and has stock/ownership interests in AseptiScope Inc, Brainbox Inc, Comprehensive Research Associates LLC, Emergencies in Medicine LLC, and Ischemia DX LLC. Dr. F. Apple's disclosures are as follows. Board of Directors, HyTest; Advisory Board, Instrumentation Laboratory, Siemens Healthineers; Consultant, LumiraDx. Non-salaried PI through the Hennepin Healthcare Research Institute for cardiac troponin studies from Abbott Diagnostics, Abbott POC, Ortho-Clinical Diagnostics; Siemens Healthineers, and Beckman Coulter. Dr. A.T. Limkakeng has received grant funding from Roche Diagnostics, Inc ., Abbott Laboratories , Bristol Meyers Squibb , Ischemia Care, LTD ., GE , and Astrazeneca . He has served as a consultant to Biomerieux and ZS Pharma. Dr. R.M. Nowak has received fees from Siemens Healthineers as a consultant for the design and conduct of this high-sensitivity cardiac troponin I trial. Additionally, he has been or is a consultant for Siemens Healthineers, Roche Diagnostics, Beckman Coulter, Ortho Diagnostics, and Abbott. Dr. J. McCord has received research support from Roche, Siemens Healthineers , Abbott , and Beckman , and has served as a consultant for Roche and Siemens Healthineers. Dr. C. deFilippi has received research support through his institution Inova . In addition, he consults for Abbott Diagnostics, FujiRebio, Metabolomics, Ortho Diagnostics, Roche Diagnostics, and Siemens Healthineers. He has received honorarium from WebMD and Royalties from UpToDate. Appendix A
    Keyword
    99th percentile
    Analytical characteristics
    Clinical performance
    High-sensitivity cardiac troponin
    Immunoassay
    Sex-specific 99th percentile cutoffs
    Identifier to cite or link to this item
    https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061806373&doi=10.1016%2fj.conctc.2019.100337&partnerID=40&md5=9eda6c1a6002df5f300429083e144ca4; http://hdl.handle.net/10713/8625
    ae974a485f413a2113503eed53cd6c53
    10.1016/j.conctc.2019.100337
    Scopus Count
    Collections
    UMB Open Access Articles

    entitlement

     
    DSpace software (copyright © 2002 - 2022)  DuraSpace
    Quick Guide | Policies | Contact Us | UMB Health Sciences & Human Services Library
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.